A case series of vildagliptin-associated bullous pemphigoid - Rare side effect
Year: 2025
Type: article
Study design: Case Report
Abstract: Vildagliptin, among the most commonly used, OHA, belongs to group dipeptidyl peptidase-4 inhibitors for managing type 2 diabetes mellitus, has recently been associated with bullous pemphigoid, characterized by fluid-filled blisters and erosions on the skin and mucous membranes. We report the series of three cases of bullous pemphigoid in patients of diabetes, who developed bullous pemphigoid after vildagliptin use.
Source: Indian Journal of Pharmacology
Authors: Mohit Kumar Shahi, JV Ashwin, Astha Singh, Suvrat Gupta, K Surya
Institution: King George's Medical University
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W4413411609